CBLL (ceribell.com) Penghasilan resik

Simbol resmi perusahaan ceribell.com (CBLL)

The market value dynamics of CeriBell, Inc. (CBLL) on the GURU.Markets platform stand at -0.07. The company's business is based on creating advanced tools for brain function analysis. The compactness of the systems simplifies their transport and reduces supply costs for clinics. The gradual integration of these technologies into medical networks creates a stable cash flow through the sale of replacement sensors, confirming sustainable growth.

Bathi resik perusahaan: CeriBell EEG (CBLL) kanggo 12.10.2024 - 29.10.2026
Produk seri CeriBell Inc

Investors assess the operational strength of an asset through its ability to generate real cash flow. For CeriBell, Inc. (CBLL), this process depends directly on the efficiency of rapid-EEG system implementation and the retention of R&D personnel. This net profit chart reflects the daily equity value of revenues, net of operating expenses. This indicator measures the actual business efficiency in real-time. A stable trajectory confirms the company's financial resilience during expansion.

Pesaing utama

Penghasilan resik perusahaan Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Bathi resik|Penghasilan resik regencellbioscience.com (RGC)|Bathi resik AXSM|ACAD - Penghasilan resik perusahaan|Bathi resik perusahaan Xenon Pharmaceuticals Inc XENE|Bathi pungkasan VKTX|Supernus Pharmaceuticals - Bathi resik|Asil keuangan resik catalystpharma.com CPRX|DNLI: Bathi resik|HRMY (Harmony Biosciences Inc) - Bathi resik perusahaan|BHVN (Biohaven Pharmaceutical) - Bathi resik|Penghasilan resik perusahaan Amylyx Corp AMLX|Bathi resik perusahaan Trevi Therapeutics (TRVI)|Bathi resik perusahaan PRAX (praxismedicines.com)|Bathi resik perusahaan Anavex Life Sciences Corp. AVXL|Prothena Corp - Bathi resik perusahaan|ALEC: Penghasilan resik|Bathi pungkasan ANNX (Annexon Biosciences Inc.)|OMER: Bathi resik|NGNE - Asil keuangan resik|Bathi resik perusahaan AC Immune SA|Bathi perusahaan VYGR (Voyager Therapeutics Inc)|Bathi resik NMRA|Penghasilan resik Scilex Holding Company, Inc. SCLX|Tevogen Bio Holdings - Penghasilan resik|Asil keuangan resik Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Bathi resik|Inhibikase Therapeutics Inc (IKT) - Penghasilan resik|SAVA: Bathi resik|ASRT (Assertio) - Bathi resik perusahaan|Bathi resik perusahaan Coya Therapeutics Inc|Bathi resik perusahaan VTGN|Bathi resik perusahaan Ovid Therapeutics Inc. (OVID)|Bathi resik perusahaan ABOS (Acumen Pharmaceuticals Inc.)|Bathi resik perusahaan CervoMed Inc CRVO|ATHE: Bathi perusahaan|Clene Nanomedicine - Bathi resik|Penghasilan resik perusahaan PepGen Inc.|JUNS (Jupiter Neurosciences Inc) - Penghasilan resik|Relmada Therapeutics Inc (RLMD) - Bathi resik|Bathi resik perusahaan Annovis Bio Corp|GRCE: Bathi pungkasan|Bathi resik perusahaan Firefly Neuroscience, Inc (AIFF)|KLTO - Penghasilan resik perusahaan|Bathi resik NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Penghasilan resik|MetaVia, Inc. - Bathi resik|Penghasilan resik perusahaan NeurAxis Inc|heliusmedical.com (HSDT) - Bathi resik perusahaan|Passage Bio - Bathi pungkasan|NEUP (Neuphoria Therapeutics, Inc.) - Bathi resik|Minerva Neurosciences Inc (NERV) - Asil keuangan resik|Bathi resik ATHA|Bathi resik perusahaan ADXN (Addex)|Bathi resik ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Penghasilan resik perusahaan|PTIX - Bathi resik perusahaan|KTTA: Bathi resik perusahaan|cortigent.com (CRGT) - Bathi resik perusahaan|ATXI (Avenue Therapeutics Inc) - Bathi resik perusahaan|Penghasilan resik BCLI|CARA: Bathi pungkasan|Bathi resik CHRO|Asil keuangan resik eliemtx.com|Bathi resik perusahaan Intra-Cellular Therapies, Inc. ITCI|LBPH: Bathi perusahaan|Marinus Pharmaceuticals - Bathi resik|nkgenbiotech.com (NKGN) - Penghasilan resik|NRBO (NeuroBo Pharmaceuticals, Inc.) - Penghasilan resik|SAGE - Asil keuangan resik|SNPX (Neurotrope) - Bathi resik|Penghasilan resik Trevena Inc (TRVN)|Bathi resik VIGL|Bathi resik perusahaan WENA (Anew Medical Inc.)|Bathi resik perusahaan Cerevel Therapeutics, Inc. CERE